Inhibitory effects of Lang-du extract on the in vitro and in vivo growth of melanoma cells and its molecular mechanisms of action

Cytotechnology

Volumn 62, Issue 4, 2010, Pages 357-366

  Wang, Liping ^a,b   Duan, Huiying ^a   Wang, Yishan ^a,b   Liu, Kun ^a   Jiang, Peng ^b   Qu, Zhen ^b   Yagasaki, Kazumi ^c   Zhang, Guoying ^a  

^a YANTAI UNIVERSITY   (China)

^b BINZHOU MEDICAL UNIVERSITY   (China)

^c TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Bcl 2 Bax; HGF; Lang du extract; Melanoma cells; OPN; Tumor growth; VEGF

Indexed keywords

LANG DU EXTRACT; OSTEOPONTIN; PLANT EXTRACT; PROTEIN BAX; PROTEIN BCL 2; SCATTER FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER SIZE; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GAMMA RADIATION; IN VITRO STUDY; IN VIVO STUDY; LANG DU; MEDICINAL PLANT; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; WESTERN BLOTTING;

ANIMALIA; EUPHORBIA FISCHERIANA; MUS;

EID: 79951671921     PISSN: 09209069     EISSN: 15730778     Source Type: Journal    
DOI: 10.1007/s10616-010-9283-z     Document Type: Conference Paper

References (48)

1. Aggarwal BB (2004) Nuclear factor-kappaB: the enemy within. Cancer Cell 6:203-208
2. Carlson JA, Linette GP, Aplin A, Ng B, Slominski A (2007) Melanocyte receptors: clinical implications and therapeutic relevance. Dermatol Clin 25:541-557 (Pubitemid 47454680)
3. Chen L, Lu Y, Wu JM, Xu B, Zhang LJ, Gao M, Zheng SZ, Wang AY, Zhang CB, Zhang WW, Lei N (2009) Ligustrazine inhibits B16F10 melanoma metastasis and suppresses angiogenesis induced by vascular endothelial growth factor. Biochem Biophys Res Commun 386:374-379
4. Das R, Mahabeleshwar GH, Kundu GC (2003) Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells. J Biol Chem 278:28593-28606 (Pubitemid 36935765)
5. Das R, Philip S, Mahabeleshwar GH, Bulbule A, Kundu GC (2005) Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression. IUBMB Life 57:441-447 (Pubitemid 41073126)
6. Eder JP, Vande Woude GF, Boerner SA, LoRusso PM (2009) Novel therapeutic inhibitors of the c-Met signaling pathway in cancer. Clin Cancer Res 15:2207-2214
7. Emi M, Kim R, Tanabe K, Uchida Y, Toge T (2005) Targeted therapy against Bcl-2-related proteins in breast cancer cells. Breast Cancer Res 7:R940-R952
8. Fan S, Gao M, Meng Q, Laterra JJ, Symons MH, Coniglio S, Pestell RG, Goldberg ID, Rosen EM (2005) Role of NFkappaB signaling in hepatocyte growth factor/scatter factor-mediated cell protection. Oncogene 24:1749-1766 (Pubitemid 40461131)
9. Goh PP, Sze DM, Roufogalis BD (2007) Molecular and cellular regulators of cancer angiogenesis. Curr Cancer Drug Targets 7:743-758
10. Govindarajan B, Sligh JE, Vincent BJ, Li M, Canter JA, Nickoloff BJ, Rodenburg RJ, Smeitink JA, Oberley L, Zhang Y, Slingerland J, Arnold RS, Lambeth JD, Cohen C, Hilenski L, Griendling K, Martínez-Diez M, Cuezva JM, Arbiser JL (2007) Overexpression of Akt converts radial growth melanoma to vertical growth melanoma. J Clin Invest 117:719-729 (Pubitemid 46348530)
11. Gupta S, Afaq F, Mukhtar H (2002) Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells. Oncogene 21:3727-3738 (Pubitemid 34620536)
12. Huang Y, Liu Q, Liu K, Yagasaki K, Zhang G (2009) Suppression of growth of highly-metastatic human breast cancer cells by norcantharidin and its mechanisms of action. Cytotechnology 59:201-208
13. Johnston NI, Gunasekharan VK, Ravindranath A, O'Connell C, Johnston PG, El-Tanani MK (2008) Osteopontin as a target for cancer therapy. Front Biosci 13:4361-4372 (Pubitemid 351599688)
14. Kerr DJ (2004) Targeting angiogenesis in cancer: clinical development of bevacizumab. Nat Clin Pract Oncol 1: 39-43 (Pubitemid 40812647)
15. Kienast Y, von Baumgarten L, Fuhrmann M, Klinkert WE, Goldbrunner R, Herms J, Winkler F (2010) Real-time imaging reveals the single steps of brain metastasis formation. Nat Med 16:116-122
16. Liu WK, Ho JC, Qin G, Che CT (2002) Jolkinolide B induces neuroendocrine differentiation of human prostate LNCaP cancer cell line. Biochem Pharmacol 63:951-957 (Pubitemid 34243008)
17. Liu Q, Duan H, Luan J, Yagasaki K, Zhang G (2009) Effects of theanine on growth of human lung cancer and leukemia cells as well as migration and invasion of human lung cancer cells. Cytotechnology 59:211-217
18. Luo H, Wang A (2006) Induction of apoptosis in K562 cells by jolkinolide B. Can J Physiol Pharmacol 84:959-965
19. Maroni P, Bendinelli P, Matteucci E, Desiderio MA (2007) HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-kappaB. Carcinogenesis 28:267-279 (Pubitemid 46321842)
20. Marsden VS, O'Connor L, O'Reilly LA, Silke J, Metcalf D, Ekert PG, Huang DC, Cecconi F, Kuida K, Tomaselli KJ, Roy S, Nicholson DW, Vaux DL, Bouillet P, Adams JM, Strasser A (2002) Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochromec/Apaf-1/caspase-9 apoptosome. Nature 419:634-637
21. Mayo LD, Donner DB (2002) The PTEN, Mdm2, p53 tumor suppressor- oncoprotein network. Trends Biochem Sci 27:462-467 (Pubitemid 35246255)
22. McGill GG, Haq R, Nishimura EK, Fisher DE (2006) c-Met expression is regulated by Mitf in the melanocyte lineage. J Biol Chem 281:10365-10373 (Pubitemid 43864575)
23. Miller AJ, Mihm MC Jr (2006) Melanoma. N Engl J Med 355:51-65
24. Nicholson KM, Anderson NG (2002) The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 14:381-395 (Pubitemid 34214843)
25. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619 (Pubitemid 23259742)
26. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB (1999) NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401:82-85
27. Patel JB, Mehta J, Belosay A, Sabnis G, Khandelwal A, Brodie AM, Soprano DR, Njar VC (2007) Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth. Br J Cancer 96:1204-1215 (Pubitemid 46628615)
28. Philip S, Bulbule A, Kundu GC (2001) Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells. J Biol Chem 276:44926-44935
29. Qin GW, Xu RS (1998) Recent advances on bioactive natural products from Chinese medicinal plants. Med Res Rev 18:375-382
30. Rangaswami H, Kundu GC (2007) Osteopontin stimulates melanoma growth and lung metastasis through NIK/MEKK1-dependent MMP-9 activation pathways. Oncol Rep 18:909-915
31. Rangaswami H, Bulbule A, Kundu GC (2004) Nuclear factorinducing kinase plays a crucial role in osteopontininduced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation. J Biol Chem 279:38921-38935 (Pubitemid 39296053)
32. Rangel J, Nosrati M, Torabian S, Shaikh L, Leong SP, Haqq C, Miller JR 3rd, Sagebiel RW, Kashani-Sabet M (2008) Osteopontin as a molecular prognostic marker for melanoma. Cancer 112:144-150
33. Sasse AD, Sasse EC, Clark LG, Ulloa L, Clark OA (2007) Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma. Cochrane Database Syst Rev 1:CD005413
34. Shibata A, Nagaya T, Imai T, Funahashi H, Nakao A, Seo H (2002) Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells. Breast Cancer Res Treat 73:237-243 (Pubitemid 34712997)
35. Sizemore N, Leung S, Stark GR (1999) Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol Cell Biol 19:4798-4805 (Pubitemid 29289518)
36. Viatour P, Bentires-Alj M, Chariot A, Deregowski V, de Leval L, Merville MP, Bours V (2003) NF- kappa B2/p100 induces Bcl-2 expression. Leukemia 17:1349-1356 (Pubitemid 36857343)
37. Villares GJ, Zigler M, Wang H, Melnikova VO, Wu H, Friedman R, Leslie MC, Vivas-Mejia PE, Lopez-Berestein G, Sood AK, Bar-Eli M (2008) Targeting melanoma growth and metastasis with systemic delivery of liposome- incorporated protease-activated receptor-1 small interfering RNA. Cancer Res 68:9078-9086
38. Wang CY, Mayo MW, Baldwin AS Jr (1996) TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274:784-787 (Pubitemid 26398259)
39. Wang YB, Huang R, Wang HB, Jin HZ, Lou LG, Qin GW (2006) Diterpenoids from the roots of Euphorbia fischeriana. J Nat Prod 69:967-970 (Pubitemid 44166276)
40. Wang Y, Ma X, Yan S, Shen S, Zhu H, Gu Y, Wang H, Qin G, Yu Q (2009a) 17-hydroxy-jolkinolide B inhibits signal transducers and activators of transcription 3 signaling by covalently cross-linking Janus kinases and induces apoptosis of human cancer cells. Cancer Res 69:7302-7310
41. Wang S, Liu Q, Zhang Y, Liu K, Yu P, Liu K, Luan J, Duan H, Lu Z, Wang F, Wu E, Yagasaki K, Zhang G (2009b) Suppression of growth, migration and invasion of highlymetastatic human breast cancer cells by berbamine and its molecular mechanisms of action. Mol Cancer 8:81
42. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292:727-730 (Pubitemid 32385543)
43. Xie TX, Xia Z, Zhang N, Gong W, Huang S (2010) Constitutive NF-kappaB activity regulates the expression of VEGF and IL-8 and tumor angiogenesis of human glioblastoma. Oncol Rep 23:725-732
44. Yan SS, Li Y, Wang Y, Shen SS, Gu Y, Wang HB, Qin GW, Yu Q (2008) 17-Acetoxyjolkinolide B irreversibly inhibits IkappaB kinase and induces apoptosis of tumor cells. Mol Cancer Ther 7:1523-1532
45. Ye M, Hu D, Tu L, Zhou X, Lu F, Wen B, Wu W, Lin Y, Zhou Z, Qu J (2008) Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells. Invest Ophthalmol Vis Sci 49:497-504
46. Yu P, Liu Q, Liu K, Yagasaki K, Wu E, Zhang G (2009) Matrine suppresses breast cancer cell proliferation and invasion via VEGF-Akt-NF-kappaB signaling. Cytotechnology 59:219-229
47. Zhang G, Miura Y, Yagasaki K (2000) Induction of apoptosis and cell cycle arrest in cancer cells by in vivo metabolites of teas. Nutr Cancer 38:265-273 (Pubitemid 32762027)
48. Zhang Y, Zhang H, Yu P, Liu Q, Liu K, Duan H, Luan G, Yagasaki K, Zhang G (2009) Effects of matrine against the growth of human lung cancer and hepatoma cells as well as lung cancer cell migration. Cytotechnology 59:191-200